Skip to main content
. 2020 Oct;9(5):1795–1809. doi: 10.21037/tlcr-20-521

Figure 5.

Figure 5

Ex vivo expansion of circulating tumour cells. (A) Isolation, expansion and characterization of CTCs from patients with advanced stage NSCLC. Cultured CTCs derived from patient blood in 96 well standard microplate. In well staining of proliferating cells in culture at day 7. Immunofluorescent staining using anti-CK-FITC and anti-CD45-APC. These cells were shown to be CD45 negative. (B) Correlation between baseline CTC count with short term culture success. CTC, circulating tumour cell.